2C Bioscience
2C Bioscience Inc. is an early-stage US biotech founded in 2025 that develops the D5+ Supplement, a cellular-innovation product supporting human embryo development in Assisted Reproductive Technology (ART) procedures, targeting fertility clinics and ART practitioners.
- Company typePrivate
- Founded2025
- HeadquartersDavis, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What 2C Bioscience does
2C Bioscience Inc. is a privately held, early-stage biotechnology company founded in 2025 and based in Davis, California, operating in the Assisted Reproductive Technology (ART) fertility market. The company's stated focus is "transforming fertility through cellular innovation," centered on human embryo development rather than traditional pharmaceutical fertility interventions.
The company's core and only disclosed product is the D5+ Supplement, a formulation designed to support human embryo development during embryo culture in ART procedures. The product is positioned for use by fertility clinics, reproductive endocrinologists, and ART practitioners who culture embryos for transfer, with fertility patients themselves identified as a secondary downstream segment. Distribution is described as flowing through fertility clinics and ART practitioners rather than direct-to-consumer channels, though no pricing, volumes, or named accounts are disclosed.
Operationally, the company is small (1-10 employees), has not announced any funding rounds, has no disclosed leadership team, no patents or trademarks, no partnerships, and no regulatory approvals in the source material. The business model, revenue mechanics, and pricing approach are not publicly disclosed, leaving the company in a pre-commercial or very early commercial posture with limited verifiable traction signals.
2C Bioscience firmographics
Firmographics- Name
- 2C Bioscience
- Legal name
- 2C Bioscience Inc.
- Website
- https://2cbioscience.com
- Company type
- Private
- Founded year
- 2025
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- 2C Bioscience Inc. is an early-stage US biotech founded in 2025 that develops the D5+ Supplement, a cellular-innovation product supporting human embryo development in Assisted Reproductive Technology (ART) procedures, targeting fertility clinics and ART practitioners.
- Ownership category
- akta.pro rank
2C Bioscience industry classification
Industry- Product category
- ART Fertility Supplements
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health) (HLAIAAAJ)
- akta.pro secondary industry
- Recombinant Protein Therapeutics (enzymes, hormones, growth factors) (HLAAAAAB)
Keywords
Where 2C Bioscience is headquartered
LocationHeadquarters
- HQ city
- Davis
- HQ country
- United States
- HQ region
- North America
Markets served
2C Bioscience business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Supply Chain, Technology or R&D, Personnel, Marketing or Sales
2C Bioscience product offering
Product offeringCore offering
2C Bioscience develops and manufactures the D5+ Supplement, a cellular innovation product designed to support embryo development within the Assisted Reproductive Technology (ART) fertility space. The product is positioned as an advanced culture media supplement for use in fertility treatment workflows.
Product overview
2C Bioscience is a biotech company developing cellular innovation technologies for fertility. The company offers the D5+ Supplement, a core product designed to support fertility and ART outcomes by promoting healthy human embryo development. The company's focus is on transforming fertility through cellular innovation, specifically targeting the journey of human embryo development.
Differentiator
Problem solved
Functional benefit
Products and services
- D5+ Supplement
Companies that use 2C Bioscience
Customer profileSegments2 records
Ideal customer profiles1 record
2C Bioscience technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
2C Bioscience partnerships and signals
Strategic signalRecent moves3 records
Expansion highlights3 records
2C Bioscience competitors and assessment
Company assessmentDirect peers
- Esco Medical: Danish manufacturer of IVF/ART equipment including MIRI time-lapse incubators and benchtop incubators, plus related ART consumables. Direct peer in the fertility clinic lab-supply category.
- Kitazato Corporation: Japanese company specializing in IVF/ART products including embryo culture media, vitrification solutions, and oocyte/embryo handling consumables. Direct peer in clinical ART media and supplements.
- Vitrolife: Swedish-listed global leader in IVF media, consumables, and time-lapse incubation systems. Directly comparable as a developer and supplier of embryo culture media and ART lab consumables to fertility clinics worldwide.
- Gynemed: German manufacturer of ART media, sperm preparation, and embryo culture products distributed globally. Direct peer in embryo culture media for IVF clinics.
- FUJIFILM Irvine Scientific: Major manufacturer of cell culture media including Continuous Single Culture (CSC) and other IVF-specific media. Directly comparable as a supplier of embryo culture media and supplements to ART labs.
- CooperSurgical (Wallace line): Through its Wallace and Origio legacy brands, CooperSurgical supplies a broad portfolio of ART/IVF media, devices, and consumables to fertility clinics. Direct peer in the IVF consumables category.
- Genea Biomedx: Australian fertility technology company developing IVF lab instruments, media, and consumables (e.g., Geri time-lapse incubator, Gems culture media). Directly comparable as an ART-focused consumables and media developer.
Others
- Progyny: US fertility benefits manager covering IVF cycles and adjuncts for employer-sponsored plans. Ecosystem participant rather than direct competitor — relevant as a potential payer/coverage channel for ART consumables like D5+.
Broad incumbents
- Corning Life Sciences: Major cell culture media and plasticware manufacturer serving research and bioprocessing broadly, including ART-adjacent cell culture applications. Broader incumbent rather than ART-specialist, but operates in the same underlying cell-culture technology space.
- Merck KGaA (Life Science / Sigma-Aldrich): Global life-science supplier of cell culture media, reagents, and embryology-relevant consumables through Sigma-Aldrich and MilliporeSigma. Broad incumbent with overlapping capability in cell culture media, though not exclusively focused on ART.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks6 records
Key highlights4 records
Customer concentration
2C Bioscience social profiles
Digital presence2C Bioscience financial estimates
Financial estimateRevenue estimate
Valuation estimate
2C Bioscience leadership team
Management profileNumber of profiles
2C Bioscience funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
2C Bioscience M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about 2C Bioscience
What does 2C Bioscience do?
2C Bioscience develops and manufactures the D5+ Supplement, a cellular innovation product designed to support embryo development within the Assisted Reproductive Technology (ART) fertility space. The product is positioned as an advanced culture media supplement for use in fertility treatment workflows.
Is 2C Bioscience a public or private company?
2C Bioscience is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was 2C Bioscience founded?
2C Bioscience was founded in 2025. It employs 1 to 10 people.
Where is 2C Bioscience based?
2C Bioscience is headquartered in Davis, United States, in the North America region.
Who are 2C Bioscience's main competitors?
Direct peers on record are Esco Medical, Kitazato Corporation, Vitrolife, Gynemed, FUJIFILM Irvine Scientific, CooperSurgical (Wallace line) and Genea Biomedx. Progyny is listed as an others. Broad incumbents are Corning Life Sciences and Merck KGaA (Life Science / Sigma-Aldrich).
Does 2C Bioscience have an API?
No public API is recorded for 2C Bioscience.
What industry is 2C Bioscience in?
2C Bioscience's product category is ART Fertility Supplements. Its primary akta.pro industry code is HLAIAAAJ, Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health), with a secondary code of HLAAAAAB, Recombinant Protein Therapeutics (enzymes, hormones, growth factors). Its NAICS code is 325414 and its SIC code is 2836.